Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Association of day-of-injury serum glial fibrillary acidic protein concentration and six-month posttraumatic stress disorder in patients with mild traumatic brain injury
    Published on 2022-06-18
    3 years ago
  • Sleep-mediated regulation of reward circuits: implications in substance use disorders
    Published on 2022-06-16
    3 years ago
  • Symptomatic and neurotrophic effects of GABAA receptor positive allosteric modulation in a mouse model of chronic stress
    Published on 2022-06-14
    3 years ago
  • The neurobiological markers of acute alcohol’s subjective effects in humans
    Published on 2022-06-14
    3 years ago
  • Haven’t lost the positive feeling: a dose-response, oral alcohol challenge study in drinkers with alcohol use disorder
    Published on 2022-06-14
    3 years ago
  • Correction to: Isoform-selective phosphoinositide 3-kinase inhibition ameliorates a broad range of fragile X syndrome-associated deficits in a mouse model
    Published on 2022-06-14
    3 years ago
  • Neural circuits regulating prosocial behaviors
    Published on 2022-06-14
    3 years ago
« Previous 1 … 131 132 133 134 135 … 143 Next »
Journal of Psychopharmacology
  • Multiple daytime administration of the selective orexin-2 receptor antagonist JNJ-42847922 induces somnolence in healthy subjects without residual central effects
    Published on 2018-09-05
    7 years ago
  • Chronic antipsychotic treatment differentially modulates protein kinase A- and glycogen synthase kinase 3 beta-dependent signaling pathways, N-methyl-D-aspartate receptor and γ-aminobutyric acid A receptors in nucleus accumbens of juvenile rats
    Published on 2018-08-23
    7 years ago
  • The effects of haloperidol on microglial morphology and translocator protein levels: An in vivo study in rats using an automated cell evaluation pipeline
    Published on 2018-08-21
    7 years ago
  • Efficacy of vortioxetine on the physical symptoms of major depressive disorder
    Published on 2018-07-26
    7 years ago
  • Towards a biomarker model for cognitive improvement: No change in memory-related prefrontal engagement following a negative cognitive remediation trial in bipolar disorder
    Published on 2018-07-04
    7 years ago
  • Amiloride modulation of carbon dioxide hypersensitivity and thermal nociceptive hypersensitivity induced by interference with early maternal environment
    Published on 2018-07-03
    7 years ago
  • Real-world effectiveness of clozapine for intellectual disability: Results from a mirror-image and a reverse-mirror-image study
    Published on 2018-06-26
    7 years ago
« Previous 1 … 131 132 133 134 Next »
European Neuropsychopharmacology
  • Methylation of oxytocin related genes and early life trauma together shape the N170 response to human faces
    Published on 2020-09-29
    5 years ago
  • Metabolic predictors for mortality among patients treated with long-term clozapine – A longitudinal study
    Published on 2020-09-26
    5 years ago
  • Value of peripheral neurotrophin levels for the diagnosis of depression and response to treatment: A systematic review and meta-analysis
    Published on 2020-09-25
    5 years ago
  • Valproic acid exposure impairs ultrasonic communication in infant, adolescent and adult rats
    Published on 2020-09-22
    5 years ago
  • Dysfunctional coupling of the parahippocampal cortex and inferior frontal gyrus during memory suppression in posttraumatic stress disorder
    Published on 2020-09-21
    5 years ago
  • A diet-induced gut microbiota component and related plasma metabolites are associated with depressive-like behaviour in rats
    Published on 2020-09-13
    5 years ago
  • Outreach and support in South-London (OASIS) 2001—2020: Twenty years of early detection, prognosis and preventive care for young people at risk of psychosis
    Published on 2020-09-11
    5 years ago
« Previous 1 … 131 132 133 134 135 … 153 Next »

   Pharma Pub